InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,698.42
(
-0.27%
)
US TECH 100
19,226.80
(
-0.56%
)
Dow Jones
42,011.46
(
-0.03%
)
Brent Oil
74.11
(
-0.28%
)
Bitcoin
62,886.75
(
-0.10%
)
Post# of 977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NY1972

Send PM Follow Ignore
Followers 4
Posts 1198
Boards Moderated 0
Alias Born 10/03/2015

NY1972

Re: None

Monday, 06/06/2016 11:46:13 AM

Monday, June 06, 2016 11:46:13 AM

Post# of 977
OX40 is one of the most-hyped cancer immunotherapy targets for its theoretical ability to improve response to currently approved checkpoint inhibitors. But this weekend, Roche's (RHHBY) OX40 drug candidate, combined with the checkpoint inhibitor Tecentriq, showed decent safety but not much else.

https://www.thestreet.com/story/13597010/2/cancer-drug-stocks-the-winners-and-losers-from-asco-2016.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!